Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
2011-7-7
pubmed:abstractText
The effects of TNF gene deletion on renal Na(+)-K(+)-2Cl(-) cotransporter (NKCC2) expression and activity were determined. Outer medulla from TNF(-/-) mice exhibited a twofold increase in total NKCC2 protein expression compared with wild-type (WT) mice. This increase was not observed in TNF(-/-) mice treated with recombinant human TNF (hTNF) for 7 days. Administration of hTNF had no effect on total NKCC2 expression in WT mice. A fourfold increase in NKCC2A mRNA accumulation was observed in outer medulla from TNF(-/-) compared with WT mice; NKCC2F and NKCC2B mRNA accumulation was similar between genotypes. The increase in NKCC2A mRNA accumulation was attenuated when TNF(-/-) mice were treated with hTNF. Bumetanide-sensitive O(2) consumption, an in vitro correlate of NKCC2 activity, was 2.8 ± 0.2 nmol·min(-1)·mg(-1) in medullary thick ascending limb tubules from WT, representing ?40% of total O(2) consumption, whereas, in medullary thick ascending limb tubules from TNF(-/-) mice, it was 5.6 ± 0.3 nmol·min(-1)·mg(-1), representing ?60% of total O(2) consumption. Administration of hTNF to TNF(-/-) mice restored the bumetanide-sensitive component to ?30% of total O(2) consumption. Ambient urine osmolality was higher in TNF(-/-) compared with WT mice (2,072 ± 104 vs. 1,696 ± 153 mosmol/kgH(2)O, P < 0.05). The diluting ability of the kidney, assessed by measuring urine osmolality before and after 1 h of water loading also was greater in TNF(-/-) compared with WT mice (174 ± 38 and 465 ± 81 mosmol/kgH(2)O, respectively, P < 0.01). Collectively, these findings suggest that TNF plays a role as an endogenous inhibitor of NKCC2 expression and function.
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jul
pubmed:issn
1522-1466
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
301
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
F94-100
pubmed:meshHeading
pubmed-meshheading:21511694-Animals, pubmed-meshheading:21511694-Blotting, Western, pubmed-meshheading:21511694-Chlorides, pubmed-meshheading:21511694-DNA, Complementary, pubmed-meshheading:21511694-DNA Fragmentation, pubmed-meshheading:21511694-Indicators and Reagents, pubmed-meshheading:21511694-Isomerism, pubmed-meshheading:21511694-Kidney Concentrating Ability, pubmed-meshheading:21511694-Kidney Function Tests, pubmed-meshheading:21511694-Kidney Medulla, pubmed-meshheading:21511694-Male, pubmed-meshheading:21511694-Mice, pubmed-meshheading:21511694-Mice, Inbred C57BL, pubmed-meshheading:21511694-Mice, Knockout, pubmed-meshheading:21511694-Osmolar Concentration, pubmed-meshheading:21511694-Oxygen Consumption, pubmed-meshheading:21511694-RNA, Messenger, pubmed-meshheading:21511694-Sodium-Potassium-Chloride Symporters, pubmed-meshheading:21511694-Tumor Necrosis Factor-alpha
pubmed:year
2011
pubmed:articleTitle
Tumor necrosis factor-alpha is an endogenous inhibitor of Na+-K+-2Cl- cotransporter (NKCC2) isoform A in the thick ascending limb.
pubmed:affiliation
Dept. of Pharmacology, New York Medical College, Valhalla, NY 10595, USA.
pubmed:publicationType
Journal Article, Research Support, N.I.H., Extramural